Kimberly-Clark (NYSE:KMB) 2026 Conference February 19, 2026 11:00 AM ET Company ParticipantsCraig Slavtcheff - Chief R&D OfficerMike Hsu - Chairman and CEOPatricia Corsi - Chief Growth OfficerRuss Torres - President and COONone - Video NarratorOperatorHi, everyone. Our next presenter is Kimberly-Clark, which is currently in the midst of one of the largest transactions and biggest corporate transformations in CPG history. The team is led by Chairman and CEO, Mike Hsu. Since taking the helm as CEO in 2019, Mi ...

KIMBERLY - CLARK CAGNY 2026 Forward-Looking Statements Certain matters contained in this presentation concerning our plans and expectations regarding the pending mergers with Kenvue and the pending International Family Care and Professional ("IFP") joint venture transaction with Suzano ("IFP Transaction"), the business outlook, including raw material, energy and other input costs, the anticipated charges and savings from the 2024 Transformation Initiative, cash flow and uses of cash, growth initiatives, inn ...

Core Insights - Kimberly-Clark Corporation, headquartered in Dallas, Texas, has a market cap of approximately $34.7 billion and is known for its leading brands such as Huggies, Kleenex, Scott, Kotex, and Depend [1] Stock Performance - Over the past 52 weeks, KMB stock has decreased by 19.4%, underperforming the S&P 500 Index, which gained 14.4%. However, in 2026, KMB shares have increased nearly 5% year-to-date, outperforming the broader index's 1.4% rise [2] Financial Results - Following the release of its fourth-quarter 2025 results, KMB shares fell 1.1%. Revenue slightly decreased year-over-year to $4.08 billion, aligning closely with the consensus estimate of $4.09 billion. Adjusted EPS rose 24% to $1.86, surpassing analysts' forecast of $1.81 [3][4] Operational Strategy - Cost controls and steady demand for core products like Huggies and Kleenex have supported financial results. The company has implemented job cuts and exited lower-margin operations, enhancing margin stability [4] - Kimberly-Clark has expanded its affordable product lineup while maintaining premium features and brand equity. The company is also advancing its transformation with a $48.7 billion acquisition of Kenvue Inc., expected to close by year-end [5] Future Outlook - For fiscal 2026, analysts project diluted EPS of $7.06, indicating a 6.2% decline. Despite this, Kimberly-Clark has consistently beaten EPS estimates in the past four quarters, demonstrating operational outperformance that mitigates concerns about near-term pressures [6]

Core Insights - Kimberly-Clark has been successfully growing volumes in a challenging consumer environment by focusing on delivering superior product propositions and accelerating innovation across its portfolio [1][3] - The company reported its eighth consecutive quarter of solid volume-plus-mix performance and gained enterprise-weighted market share [2][5] - Management anticipates continued consumer pressure and a focus on value, leading to strategic adjustments in pricing and product offerings [6][12] Financial Performance - In Q4 2025, Kimberly-Clark achieved strong productivity, marking the strongest quarter of the year [2][3] - The company expects largely flat costs for 2026, with a productivity target of approximately 6% and aims for margin expansion [4][17] - Long-term targets include achieving at least 40% adjusted gross margin and 18-20% operating margin before 2030 [4][17] Strategic Initiatives - The planned acquisition of Kenvue is expected to enhance Kimberly-Clark's position in higher growth, higher-margin personal care categories [4][15] - Management is focused on maintaining healthy investment levels across the value chain while adapting to consumer trends [1][6] Market Dynamics - The company anticipates a partial loss of diaper distribution in the North American club channel starting in Q1, which is expected to impact full-year results by approximately 60 basis points [5][13] - Despite this, Kimberly-Clark reported global share gains in diapers across several markets, including a 100 basis point increase in North America in Q4 [14] Category Growth Expectations - The global category growth outlook for 2026 is projected to be around ±2%, with some recent fluctuations noted [7][16] - The company expects organic growth to accelerate in the second half of 2026, supported by innovation and brand initiatives [16] Pricing and Consumer Behavior - Management noted that promotional activity remains below category levels, and the company intends to maintain pricing discipline while growing volume and mix profitably [12][18] - Shifts in consumer purchasing behavior, including a move towards larger pack sizes and club channels, are influencing pricing strategies [11][6]

Financial Data and Key Metrics Changes - In 2025, the company achieved approximately 2% volume-led organic growth, with 3% volume plus mix growth in Q4 despite a slowdown in global weighted average category growth to about 60 basis points [38][39] - Adjusted free cash flow for the year was $1.9 billion, consistent with previous estimates, indicating strong cash generation capabilities [39] - The company reported industry-leading gross productivity at 6.2% of Adjusted COGS, peaking at 7.2% in Q4, exceeding expectations [15] Business Line Data and Key Metrics Changes - The personal care business led productivity improvements, with significant progress in baby and childcare categories, reducing product platforms from 30 to 11 [16] - Innovations in personal care, such as Huggies' new products, contributed to share gains in key markets, with Huggies gaining nearly 50 basis points of share in Brazil in Q4 [23][28] - The company maintained healthy margins and strong exit momentum in Q4, with broad-based volume-led organic growth across all IPC focus markets [22] Market Data and Key Metrics Changes - In China, the company gained over 900 basis points of share in diapers over the past five years, while local competitors shifted focus to other markets [21] - The international personal care business saw broad-based share gains, with all focus markets delivering volume-led organic growth in Q4 [22] - The North American market demonstrated resilience, with positive volume mix-led growth for three consecutive years, despite competitive pressures [27][28] Company Strategy and Development Direction - The company is pivoting towards higher growth, higher margin personal care categories, including the sale of its Brazilian tissue operations and PPE business [4] - The acquisition of Kenvue is seen as a strategic move to enhance growth and create a consumer-centric health and wellness leader [5][6] - The company aims to achieve $2.1 billion in annual synergies from the Kenvue acquisition, with a focus on cost synergies and EPS accretion [7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate a challenging environment, emphasizing a commitment to innovation and brand support [11][19] - The outlook for 2026 includes expectations for mid- to high-single-digit constant currency adjusted EPS growth, driven by the Kenvue acquisition and ongoing operational improvements [46][47] - The company anticipates continued pressure on consumers and a focus on value, but remains optimistic about its growth initiatives [11] Other Important Information - The company has made significant investments in its North American manufacturing footprint, including a $2 billion investment to enhance its supply chain [16] - The Powering Care strategy has created a virtuous cycle of growth, enabling the company to maintain resilience amid external challenges [10][12] - The company has improved its cash conversion cycle significantly, moving from 6 days in 2021 to around negative 10 days by the end of 2025 [43] Q&A Session Summary Question: What are the expectations for the Kenvue acquisition? - The company expects the Kenvue acquisition to enhance growth and create significant value for shareholders, with a focus on achieving synergies and integrating the brands effectively [7][45] Question: How is the company addressing competitive pressures? - Management highlighted a disciplined approach to innovation and marketing, which has allowed the company to maintain market share and drive growth despite competitive challenges [19][27] Question: What is the outlook for 2026? - The company projects mid- to high-single-digit constant currency adjusted EPS growth for 2026, supported by strong operational performance and the Kenvue acquisition [46][47]

Financial Data and Key Metrics Changes - In 2025, the company achieved approximately 2% organic growth, supported by 3% volume plus mix growth, despite a slowdown in global weighted average category growth to roughly 60 basis points in Q4 [38][39] - Adjusted Free Cash Flow for the year was $1.9 billion, consistent with previous estimates, indicating strong cash generation capabilities [39] - The company reported industry-leading gross productivity at 6.2% of Adjusted COGS for the year, peaking at 7.2% in Q4, exceeding expectations [15] Business Line Data and Key Metrics Changes - The Personal Care business led the way in productivity improvements, with significant progress in delivering high-performing products at lower costs [16] - Innovations in the Personal Care segment, such as Huggies' new products, contributed to strong volume-led organic growth, particularly in key markets like China and Brazil [22][24] - The company exited a large private label diaper contract in North America, which impacted the overall performance but was part of a strategic realignment [38] Market Data and Key Metrics Changes - In the international Personal Care business, the company gained over 900 basis points of share in diapers over the past five years, while local competitors have struggled [20] - The company saw broad-based share gains in international focus markets, with all focus markets delivering volume-led organic growth in Q4 [22] - In North America, the company achieved a volume plus mix growth of 1.8% in Q4, with Personal Care growing value share by 20 basis points for the year [28] Company Strategy and Development Direction - The company is focused on transforming into a pure-play Personal Care company, pivoting its portfolio towards higher growth and higher margin categories [4] - The acquisition of Kenvue is seen as a strategic move to enhance growth and create a consumer-centric health and wellness leader [5][7] - The company aims to leverage its operating momentum to create significant value for shareholders and improve care standards for consumers globally [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate a challenging environment, citing strong execution of the Powering Care strategy as a key driver of success [19] - The outlook for 2026 includes expectations for mid- to high-single-digit constant currency growth in Adjusted Operating Profit, supported by a robust pipeline of initiatives [46][47] - Management acknowledged ongoing consumer pressure and a focus on value, indicating that these factors will persist in the near term [11] Other Important Information - The company has made significant investments in its North American manufacturing footprint, including a $2 billion investment to enhance its capabilities [16] - The integration of Kenvue is being led by a dedicated team, with strong progress reported in the early stages [18] - The company has achieved a strong cash conversion cycle improvement, going from 6 days in 2021 to around negative 10 days at the close of 2025 [43] Q&A Session Summary Question: What are the expectations for the Kenvue acquisition? - Management expects the Kenvue acquisition to create significant value and enhance growth, with a target of generating $2.1 billion in annual synergies net of reinvestment [7][51] Question: How is the company addressing competitive pressures? - The company is focused on out-innovating and out-marketing competitors, maintaining a disciplined approach to brand investments and consumer engagement [19][27] Question: What is the outlook for Adjusted EPS growth? - The company anticipates double-digit growth in Adjusted EPS from continuing operations on a constant currency basis, driven by the Kenvue acquisition and ongoing operational improvements [47][48]

Financial Data and Key Metrics Changes - In 2025, the company achieved approximately 2% volume-led organic growth, with a strong performance in the fourth quarter, delivering 3% volume plus mix growth despite a slowdown in global weighted average category growth to roughly 60 basis points [38][39] - Adjusted free cash flow for the year was $1.9 billion, consistent with previous estimates, indicating the company's ability to maintain performance across quarters [39][45] - The company reported industry-leading gross productivity at 6.2% of Adjusted COGS, peaking at 7.2% in the fourth quarter, exceeding expectations [15] Business Line Data and Key Metrics Changes - The personal care business led the way in productivity improvements, with significant progress in categories like baby and childcare, which are highly competitive [16] - The company pivoted its portfolio towards higher growth, higher margin personal care categories, including the sale of its Brazilian tissue operations and PPE business, and exiting approximately $650 million of private label business [4][5] - Innovations in the personal care segment, such as Huggies' new products, contributed to strong volume growth and market share gains in various regions [24][28] Market Data and Key Metrics Changes - In international personal care markets, the company gained over 900 basis points of share in diapers over the past five years, while local competitors shifted focus away from China [20] - The company saw broad-based share gains in international personal care focus markets, with all focus markets delivering volume-led organic growth in Q4 [21][22] - In North America, the company achieved a third consecutive year of positive volume mix-led growth, with personal care growing value share by 20 basis points [27][28] Company Strategy and Development Direction - The company is focused on its "Powering Care" strategy, which emphasizes innovation, cost discipline, and a pivot towards higher margin categories [3][4] - The acquisition of Kenvue is seen as a significant step in the company's transformation, expected to enhance growth and create a scaled health and wellness leader [5][6] - The company aims to build a consumer-centric care model with a portfolio of ten iconic billion-dollar brands across critical life stages [5] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate a challenging environment, citing strong execution and a focus on innovation-led growth [19][39] - The outlook for 2026 includes expectations for mid- to high-single-digit constant currency adjusted EPS growth, driven by the Kenvue acquisition and ongoing operational improvements [47][48] - The company anticipates continued pressure on consumers and a focus on value, but remains committed to supporting its brands and driving growth initiatives [11][47] Other Important Information - The company has made significant investments in its North American manufacturing footprint, including a $2 billion investment to build an advanced manufacturing facility and an automated distribution center [16] - The company has improved its cash conversion cycle from 6 days in 2021 to around negative 10 days at the close of 2025, reflecting better working capital discipline [43] - The company has achieved a strong overhead leverage, expanding adjusted operating profit margins by 100 basis points over the past two years [42] Q&A Session Summary Question: What are the expectations for the Kenvue acquisition? - Management expects the Kenvue acquisition to be quickly accretive to earnings and value-enhancing for shareholders, with a focus on achieving significant synergies [37][53] Question: How is the company addressing competitive pressures? - The company is maintaining a disciplined approach to innovation and marketing, focusing on delivering superior consumer value propositions to navigate competitive pressures [19][27] Question: What is the outlook for 2026? - The company projects mid- to high-single-digit constant currency adjusted EPS growth for 2026, supported by the Kenvue acquisition and ongoing operational improvements [47][48]

POWERING CARE Forward-Looking Statements Certain matters contained in this presentation concerning our plans and expectations regarding the pending mergers with Kenvue and the pending International Family Care and Professional ("IFP") joint venture transaction with Suzano ("IFP Transaction"), the business outlook, including raw material, energy and other input costs, the anticipated charges and savings from the 2024 Transformation Initiative, cash flow and uses of cash, growth initiatives, innovations, mark ...

Core Viewpoint - Kimberly-Clark Corporation is actively pursuing a nearly $49 billion acquisition of Kenvue, which is seen as a bold move given Kenvue's stock has significantly decreased since its public offering [2] Group 1: Company Overview - Kimberly-Clark Corporation manufactures personal care products, including diapers, wipes, feminine and incontinence care products, and household paper goods [2] - The company's notable brands include Huggies, Kotex, Depend, Kleenex, Scott, and Cottonelle [2] Group 2: Acquisition Details - The planned acquisition of Kenvue includes its well-known over-the-counter products such as Tylenol, Band-Aids, and Aveeno [2] - Concerns have been raised regarding the potential risks associated with Kenvue, particularly related to Tylenol and its alleged links to autism, as mentioned by the Secretary of Health and Human Services [2] Group 3: Market Perspective - Jim Cramer highlighted that the weakness in Kimberly-Clark's stock may be more related to Kenvue's issues rather than Kimberly-Clark itself [1] - The company currently offers a 5% yield and is trading at 13 times earnings, which Cramer finds intriguing [1]

Core Insights - Kimberly-Clark Corporation (KMB) has a market capitalization of $35.5 billion and operates globally in the personal care and tissue products sector, with well-known brands such as Huggies, Kotex, Depend, Kleenex, and Scott [1][2] Financial Performance - In Q3 2025, Kimberly-Clark reported net sales of $4.15 billion and adjusted EPS of $1.82, exceeding expectations. Overall volumes grew by 2.4%, and organic sales in North America increased by 2.7%, indicating resilient demand for household staples despite pricing pressures [5] - Year-to-date, KMB stock is down 18.4%, underperforming the Nasdaq Composite's gain of 21.3%. Over the past 52 weeks, KMB shares have declined by 23.4%, compared to the Nasdaq's return of 20.7% [4] Stock Performance - Shares of Kimberly-Clark have pulled back 28.9% from their 52-week high of $150.45 and have declined nearly 17% over the past three months, lagging behind the Nasdaq Composite's over 10% increase during the same period [3][4] - The stock has been trading mostly below its 50-day and 200-day moving averages since late April [4] Competitive Landscape - In comparison, Procter & Gamble (PG) has experienced a less pronounced decline, with shares down 18.8% over the past 52 weeks and 13% year-to-date. Analysts maintain a moderately optimistic outlook for PG, with a consensus rating of "Moderate Buy" and a mean price target of $124.62, representing a 16.5% premium to current levels [6]